Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can equal pA2 values be compatible with receptor differences?

R B Raffa, J L Vaught, F Porreca

    Trends in Pharmacological Sciences
    |May 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The α2,3-selective potentiator of GABA<sub>A</sub> receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats.

    Pharmacology, biochemistry, and behavior·2019
    Same author

    Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.

    Journal of neurophysiology·2015
    Same author

    Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects.

    The Journal of pharmacology and experimental therapeutics·2013
    Same author

    Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans.

    Journal of neurophysiology·2013
    Same author

    Pharmacological activity of a Bv8 analogue modified in position 24.

    British journal of pharmacology·2011
    Same author

    [Health status and life style in Castel Malnome (Rome, I-II cent. A. D.)].

    Medicina nei secoli·2011
    Same journal

    Targeting developmental reprogramming: hPSC insights for cancer interception.

    Trends in pharmacological sciences·2026
    Same journal

    July 2026 issue first authors.

    Trends in pharmacological sciences·2026
    Same journal

    Chronobiomaterials for circadian-aligned brain therapeutics.

    Trends in pharmacological sciences·2026
    Same journal

    Biosensors for translatable GPCR bias.

    Trends in pharmacological sciences·2026
    Same journal

    ECM stiffness and epigenetics in organ fibrosis.

    Trends in pharmacological sciences·2026
    Same journal

    Which HTT transcript to lower?

    Trends in pharmacological sciences·2026
    See all related articles

    pA2 analysis can conflict with other evidence for receptor differentiation. Considering accessory binding sites reveals that equal or unequal pA2 values do not definitively confirm or deny receptor identity.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Receptor Theory

    Background:

    • pA2 analysis is a common method for receptor differentiation.
    • Conflicting conclusions can arise between pA2 analysis and other evidence.
    • The concept of accessory binding sites is crucial for interpreting receptor interactions.

    Purpose of the Study:

    • To address conflicts in receptor differentiation conclusions derived from pA2 analysis.
    • To examine the role of accessory binding sites in interpreting pA2 values.
    • To use delta-opioid receptor-mediated antinociception as a case study.

    Main Methods:

    • Re-evaluation of pA2 analysis in the context of accessory binding sites.
    • Analysis of the delta-opioid receptor system and its antinociceptive effects.

    Related Experiment Videos

  • Theoretical consideration of how accessory binding sites influence pA2 values.

    • Main Results:

    • The presence of accessory binding sites can explain discrepancies in receptor differentiation.
    • Equal pA2 values do not necessitate action at the identical receptor.
    • Unequal pA2 values do not conclusively prove action at distinct receptors.

    Conclusions:

    • pA2 analysis requires careful interpretation, especially when accessory binding sites are involved.
    • Findings from pA2 analysis should be reconciled with other lines of evidence.
    • The delta-opioid receptor controversy highlights the limitations of pA2 analysis without considering accessory binding.